can you take semaglutide if you don't have a thyroid Ozempic Condition? Semaglutide (Ozempic) carries FDA warnings

Tirzepatide targets both GIP and GLP-1 receptors (dual agonist)

Many patients taper to a lower maintenance dose once they reach goal weight, or stop entirely if they have built sustainable nutrition and lifestyle habits

Unlike the injection, which can be given at any time, the pill requires a strict fasting window

Regulatory and FDA Considerations The regulatory landscape for GLP-1 weight loss medications has been evolving

Unsaturated fatty acid-doped liposomes deliver piperine to deactivate defensive mechanism for ferroptosis in cancer therapy

And a study published in January 2025 suggested that popular GLP-1 medications approved for weight loss, diabetes and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections and some kinds of cancer and dementia